Related Experiment Video
Updated: Jul 26, 2025

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
Published on: September 23, 2022
Mesenchymal Stem Cells-Derived Apoptotic Extracellular Vesicles (ApoEVs): Mechanism and Application in Tissue
Yufan Zhu1, Xihang Chen1, Yunjun Liao1
1Department of Plastic and Cosmetic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Abstract:
Mesenchymal stem cells (MSCs) are commonly used as a source for cellular therapy owing to their strong immunosuppressive and regenerative effects. However, MSCs undergo extensive apoptosis within a short period after transplantation. During apoptosis, MSCs generate several apoptotic extracellular vesicles (MSCs-ApoEVs). MSCs-ApoEVs are rich in miRNomes, metabolites, and proteomes. They are critical intercellular communication mediators that can exert different regulatory effects on recipient cells. MSCs-ApoEVs have been shown to promote regeneration in the skin, hair, bone, muscle, and vascular system, etc. This review describes the production, release, isolation, and functionality of ApoEVs in detail. Furthermore, we summarize the existing mechanisms of MSCs-ApoEVs used for tissue regeneration and evaluate the possible strategies for their clinical application.
Insights
Mesenchymal stem cell-derived apoptotic extracellular vesicles (MSCs-ApoEVs) show promise for tissue regeneration. These vesicles, released during cell death, mediate intercellular communication and promote healing across various tissues.
Area of Science:
- Cellular Biology
- Regenerative Medicine
- Biotechnology
Background:
- Mesenchymal stem cells (MSCs) are vital for cellular therapy due to their immunosuppressive and regenerative properties.
- MSCs experience significant apoptosis post-transplantation, releasing apoptotic extracellular vesicles (MSCs-ApoEVs).
- MSCs-ApoEVs are potent intercellular communicators, rich in bioactive molecules like miRNomes, metabolites, and proteomes.
Conclusions:
- MSCs-ApoEVs represent a promising cell-free therapeutic approach for tissue regeneration.
- Understanding their mechanisms and optimizing their application are key for clinical translation.
- Further research into MSCs-ApoEVs can unlock new regenerative medicine strategies.
Related Concept Videos
Mesenchymal Stem Cells
Clinical Applications of Epidermal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Apoptosis
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Adult Stem Cells

